Successful treatment of angiosarcoma with liposomal-encapsulated doxorubicin;Erfolgreiche therapie eines angiosarkoms mit liposomal verkapseltem doxorubizin

Hautarzt

Volumn 52, Issue 10, 2001, Pages 895-898

  Voss A ^a   Seitz, C S ^a   Rose, C ^a   Brocker E B ^a   Goebeler, M ^a  

^a UNIVERSITY OF WÜRZBURG   (Germany)

Author keywords

Angiosarcoma; Cutaneous; Doxorubicin

Indexed keywords

COBALT 60; DOXORUBICIN; DOXORUBICIN DERIVATIVE; UNCLASSIFIED DRUG;

AGED; ANGIOSARCOMA; ARTICLE; CANCER CHEMOTHERAPY; CANCER PALLIATIVE THERAPY; CANCER REGRESSION; CASE REPORT; CLINICAL FEATURE; COBALT THERAPY; DISEASE COURSE; DRUG EFFICACY; DRUG TOLERABILITY; ENCAPSULATION; FEMALE; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; TREATMENT FAILURE; TREATMENT OUTCOME;

AGED, 80 AND OVER; ANTINEOPLASTIC AGENTS; DOXORUBICIN; DRUG CARRIERS; FEMALE; HEMANGIOSARCOMA; HUMANS; LEG; LIPOSOMES; SKIN NEOPLASMS; TREATMENT OUTCOME;

EID: 0034784390     PISSN: 00178470     EISSN: None     Source Type: Journal    
DOI: 10.1007/s001050170056     Document Type: Article

References (19)

1. Angiosarkome
2. Cutaneous vascular proliferations. Part III. Malignant neoplasms, other cutaneous neoplasms with significant vascular component, and disorders erroneously considered as vascular neoplasms
3. Malignant angioendothelioma of the skin
4. Herpesvirus-like DNA sequence in angiosarcoma in a patient without HIV infection
5. Absence of Kaposi's sarcoma-associated virus (human herpesvirus-8) sequences in angiosarcoma
6. Lymphangiosarcoma in postmastectomy lymphedema
7. Lymphangiosarcoma associated with chronic filarial lymphedema
8. Angiosarcoma in congenital hereditary lymphedema (Milroy's diesease) - Diagnostic beacons and a review of the literature
9. Angiosarcoma in postsurgical lymphedema. An unusual occurence in man
10. Angiosarcoma of the face and skalp, prognosis and treatment
11. Angiosarcomas of the head and neck: Clinical and pathological characteristics
12. Angiosarcoma of skin and soft tissue: A study of forty-four cases
13. Angiosarcoma of the head and neck
14. Phase II trial of paclitaxel in patients with soft-tissue sarcoma
15. Therapeutic efficay of interferon alfa-2a and 13-cis-retinoic acid in recurrent angiosarcoma of the head
16. Regression of metastatic angiosarcoma of the skin after systemic treatment with liposome-encapsulated doxorubicin and interferon-α
17. Efficacy and safety of Stealth liposomal doxorubicin in AIDS-related Kaposi's sarcoma
18. Polyethylene glycol-liposomal doxorubicin. A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic efficacy in the management of AIDS-related Kaposi's sarcoma
19. Polyethylene glycol-coated (pegylated) liposomal doxorubicin. Rationale for use in solid tumours